CDKN2A was significantly upregulated in 32 tumor types, while its expression was significantly decreased in TGCTs (Testicular Germ Cell Tumors) (tumor: 1.59 ± 1.22, normal: 4.30 ± 1.19, p = 3.7e-39; Fig. 5). The gene discussed is CDKN2A; the disease is neoplasm.